Abstract:Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are progressive and disabling inflammatory disorders of the intestine. The precise etiology of IBD is still unknown. However, the disease pathogenesis may be triggered by the interaction between genetic susceptibility, environmental factors, and gut microbiota, resulting in a dysregulated immune response to bowel damage. Concerning genetic factors, IBD are considered polygenic disorders. A family history of IBD is the most important independent risk factor for the disease: about 12–15% of the patients report having a first-degree relative suffering from the same disease [1]. Moreover, monozygotic twins have concordance rates of 6–13% [2]. In the last decade, genome-wide association studies (GWAS) have identified more than 200 genetic loci for IBD, many of which are implied in microbiological sensing, microbiome–host interactions, innate immunity, and T-cell regulation (i.e. HLA, NOD2, Il23R, STAT3, JAK2, etc.) [3–5]. Beyond the recognized immunological mechanisms, there is a growing body of evidence supporting a link between IBD and stress, depression and anxiety-spectrum disorders. Crosssectional prevalence rates of depressive and anxiety disorders among patients with IBD range from 15% to 40% and from 20% to 30%, respectively, that are higher than expected in the general population worldwide [6,7]. Rates of depressive or anxiety symptoms are even higher, reaching 50% [6,7]. The burden of depressive or anxiety comorbidity is associated with an increased risk of flares, hospitalization, and surgery, resulting in a worse course and prognosis [8]. Whether mental disorders are consequent to IBD development or share the same pathogenesis and/or causative agents is still debated. However, recent longitudinal evidence pointed to a bidirectional relationship between mental disorders and IBD, likely related to interconnections between the neuroendocrine network, the autonomous nervous system, and the gastrointestinal tract, within the brain-gut axis [9–11]. Mental disorders, especially depression, present pathophysiological mechanisms similar to IBD, including increased proinflammatory cytokines and C-reactive protein (CRP), oxidative stress, gut permeability, and dysbiosis [12]. Many inflammatory signaling pathways (i.e. IL1-6, IL-23 and CRP) partially arise from the parasympathetic and hypothalamus-pituitary-adrenal (HPA) axis dysregulation that has been found in mental disorders, including schizophrenia, bipolar disorders, and depression [12]. Furthermore, antidepressants’ (i.e. SSRI, TCA or SNRI) beneficial effects on the IBD course or development are thought to be related not only to a general relief of depressive or anxiety symptoms but mainly to their anti-inflammatory properties and capability of increasing the parasympathetic anti-inflammatory activity [11]. Taken together, this evidence suggests that shared pathways may contribute to the interactions between mental disorders and IBD. In line with this, some authors suggest that depressive symptoms can be even considered as an ‘extra-intestinal manifestation’ of inflammation [10]. Because HPA axis plays a crucial role in the endocrine, immune, and neural crosstalk between gut and brain, its involvement in functional and genetic susceptibility to IBD deserves investigation, as well as it is a plausible candidate in the connection of IBD with mental disorders. In this paper, we examine and summarize the role of the HPA axis in the pathogenesis of IBD, emphasizing the latest evidence on the genetic predisposition of loci involved in this pathway.

Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Genetic Overlap Between Inflammatory Bowel Disease and Neurological Disorders: Insights from GWAS and Gene Expression Analysis

Temporal Changes in Brain Morphology Related to Inflammation and Schizophrenia: an Omnigenic Mendelian Randomization Study.

Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder

Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk

Estimation of the Bidirectional Relationship Between Schizophrenia and Inflammatory Bowel Disease Using the Mendelian Randomization Approach

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

OP08 Multi-ancestry genome-wide association study of inflammatory bowel disease identifies 125 novel loci and directly implicates new genes in disease susceptibility

Evidence for Shared Genetic Aetiology Between Schizophrenia, Cardiometabolic, and Inflammation-Related Traits: Genetic Correlation and Colocalization Analyses

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Identification of A Common Variant with Potential Pleiotropic Effect on Risk of Inflammatory Bowel Disease and Colorectal Cancer

Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort

Comparative Single-Cell Association Analysis of Inflammatory Bowel Disorders

Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study

Genetic susceptibility to inflammatory bowel disease: should we be looking to the hypothalamus?

Genome-wide Association Identifies Multiple Ulcerative Colitis Susceptibility Loci

Biological Insights from Schizophrenia-associated Loci in Ancestral Populations

Unraveling the Genetic Susceptibility of Irritable Bowel Syndrome: integrative genome-wide analyses in 845,492 individuals: a diagnostic study